Delivery Order SPE2DB22D2007-SPE2DB24FJ0YD
Award Date 3/26/24
Potential Completion Date 4/16/24
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $7,845.72 firm-fixed-price delivery order is for the supply of IMBRUVICA 140 mg capsules under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA. This single-award IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,845.72, is a firm fixed price delivery order for the medication Imbruvica 140 mg capsules. It does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order placed by the Defense Logistics Agency (DLA) for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price of $7,322.67 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense under an indefinite...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $7,322.67 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to military...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $7,845.72 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of July 8, 2024 and was awarded on June 13, 2024. This order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $7,322.67 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IMBRUVICA 420 MG TABLET 28S. This order is a part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC, which does not have a set-aside designation,...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $7,845.72, is for the delivery of Imbruvica 140 mg capsules over a period ending on March 20, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will supply this pharmaceutical product to support military treatment programs and facilities....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564994962 IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,322.67, is a Firm Fixed Price Delivery Order with a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price Delivery Order contract is for the provision of the drug IMBRUVICA 280 MG TABLET 28S. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of IMBRUVICA 280 MG TABLET 28S to the Defense Logistics Agency (DLA). The $36,613.35 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support Department of Defense (DoD) facilities globally....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0YDDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, involves the delivery of IMBRUVICA 140 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $23,537.16, has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have a set-aside designation.
Generated 6/25/24, 1:44 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 3/26/24 |